(127 days)
Not Found
No
The description focuses on data acquisition, storage, and transfer, with no mention of AI/ML for analysis or interpretation. The "Mentions AI, DNN, or ML" section is explicitly marked as "Not Found".
No
The device is a Holter recorder used for continuous ECG recording and monitoring cardiac functionality, not for providing therapy.
Yes
Explanation: The device is a Holter recorder used to acquire and store continuous electrocardiographic (ECG) data for patients, particularly those with symptoms like palpitations, syncope, or chest pain. This data is then evaluated to judge cardiac functionality, which is a diagnostic process. While the device itself records and stores the data, the 'Intended Use' clearly states it's for patients who "may benefit from a long-term continuous electrocardiographic (ECG) recording, including, but not limited to, those with complaints of palpitations, syncope, chest pain, shortness of breath, or those that need to be monitored to judge their current cardiac functionality." This monitoring and data collection directly serves a diagnostic purpose, even if the final interpretation is done by a physician.
No
The device description clearly states it is a "Holter recorder" which is a hardware device designed to acquire and store ECG signals. While it utilizes software for data download and interaction, the core medical device is the physical recorder.
Based on the provided information, the SEER 1000 is not an IVD (In Vitro Diagnostic) device.
Here's why:
- IVD devices are used to examine specimens derived from the human body. The SEER 1000 is a Holter recorder that acquires ECG signals directly from the patient's chest surface. It does not analyze blood, urine, tissue, or any other bodily fluid or substance.
- The intended use describes recording and monitoring cardiac electrical activity. This is a physiological measurement taken directly from the patient, not an analysis of a biological sample.
- The device description focuses on acquiring and storing ECG data. This process involves electrodes placed on the skin, not the collection and analysis of a specimen.
Therefore, the SEER 1000 falls under the category of a medical device used for physiological monitoring, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The SEER 1000 digital Holter recorder is intended to continuously record ECG data. The SEER 1000 performs no cardiac analysis by itself and is intended to be used with an ECG analysis software package. The recorded data are downloaded to a PC for analysis and subsequent evaluation by a trained physician or health care professional.
The SEER 1000 is a Holter recorder which is indicated for patients who may benefit from a long-term continuous electrocardiographic (ECG) recording, including, but not limited to, those with complaints of palpitations, syncope, chest pain, shortness of breath, or those that need to be monitored to judge their current cardiac functionality.
Product codes (comma separated list FDA assigned to the subject device)
MWJ
Device Description
The SEER 1000 Holter recorder is designed to acquire ambulatory 2 or 3 channels of ECG signal from the chest surface of patients for up to 7 days. The device stores the acquired ECG data in its on-board flash memory. Patient demographic information can be downloaded from a PC application or from a mobile application (IPhone, IPod, IPad) into the SEER 1000 recorder via Bluetooth during hookup time. With the PC application or mobile application you can start or stop a recording and you can check signal quality of the ECG data during hookup time or recording. At the end of the recording, the SEER 1000 can be directly connected to a PC via an USB cable to download the recorded data for later evaluation. It is not possible to connect an USB cable and an ECG patient cable to the recorder at the same time.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
chest surface
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained physician or health care professional
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical testing that has been conducted includes:
- a. Electromagnetic compatibility evaluation according to IEC 60601-1-2;
- b. Electrical safety test according test to IEC 60601-1
- c. ECG performance test according to AAMI ANSI EC 38
None of the testing demonstrated that the SEER 1000 brought up any issues of safety or effectiveness.
No clinical testing was performed in order to support safety or effectiveness.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.2800 Medical magnetic tape recorder.
(a)
Identification. A medical magnetic tape recorder is a device used to record and play back signals from, for example, physiological amplifiers, signal conditioners, or computers.(b)
Classification. Class II (performance standards).
0
JUL 2 6 2013
| DHF - Technical Documentation | Image: getemed logo |
|---|---|
| SEER 1000 | 1015-TD-0073-00 |
| 510(K) SUMMARY | 2013-03-19 |
510(K) SUMMARY
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SDMA 1990 and 21 CFR §807.92.
The assigned 510(k) number is:
1. Submitter's Identification:
GETEMED Medizin- und Informationstechnik AG Oderstrasse 77, 14513 Teltow, Germany Tel: + 49 3328 3942 0
Contact: Dr. Bert Schadow Regulatory Affairs Manager GETEMED Medizin- und Informationstechnik AG Oderstrasse 77, 14513 Teltow, GERMANY Tel: + 49 3328 3942 70 Fax: +49 3328 3942 99
Date Summary prepared: 2013-03-19
-
- Name of the Device: SEER 1000
-
- Device Class: Class II
-
- Common or Usual Name: Holter ECG recorder without Analysis
5. Predicate Device Information:
| Device | Manufacturer | 510(k) Number |
|---|---|---|
| SEER Light Extend Compact | ||
| Digital Holter System | GE Medical Systems | |
| Information Technologies | K050731 | |
| CardioMem® CM 3000-12BT | GETEMED Medizin- und | |
| Informationstechnik AG | K063042 |
1
| DHF - Technical Documentation
| Image: getemed logo | |
|---|---|
| SEER 1000 | 1015-TD-0073-00 |
| 510(K) SUMMARY | 2013-03-19 |
6. Device Description:
The SEER 1000 Holter recorder is designed to acquire ambulatory 2 or 3 channels of ECG signal from the chest surface of patients for up to 7 days. The device stores the acquired ECG data in its on-board flash memory. Patient demographic information can be downloaded from a PC application or from a mobile application (IPhone, IPod, IPad) into the SEER 1000 recorder via Bluetooth during hookup time. With the PC application or mobile application you can start or stop a recording and you can check signal quality of the ECG data during hookup time or recording. At the end of the recording, the SEER 1000 can be directly connected to a PC via an USB cable to download the recorded data for later evaluation. It is not possible to connect an USB cable and an ECG patient cable to the recorder at the same time.
7. Intended Use:
The SEER 1000 digital Holter recorder is intended to continuously record ECG data. The SEER 1000 performs no cardiac analysis by itself and is intended to be used with an ECG analysis software package. The recorded data are downloaded to a PC for analysis and subsequent evaluation by a trained physician or health care professional.
8. Comparison to Predicate Devices:
The SEER 1000 Holter recorder is substantially equivalent to the Holter recorder CardioMem® CM 3000-12BT (K063042) from GETEMED Medizinund Informationstechnik AG and the SEER Light Extend Compact Digital Holter System (K050731) from GE Medical Systems Information Technologies. All Holter recorders record ECG data and don't perform cardiac analysis by themselves. Only some incremental changes in the SEER 1000 were made to improve the usability, the design and to bring the technical details up-to date. Wireless technology is used in the SEER Light (infrared) and CM 3000-12BT and the SEER 1000 (Bluetooth) to transfer patient data and to check the signal quality of ECG data during hookup time and recording. The SEER Light and the SEER 1000 have to be connected to a PC to read out the recorded ECG data for later evaluation. The SEER 1000 design (device without display) and operating principle (handling) is identical to the SEER Light. The SEER Light Extend Controller and the SEER 1000 PC and mobile application are both used to transfer patient data and to check the signal quality of ECG data. No influence on safety and effectiveness has been found.
2
DHF - Technical Documentation
510(K) SUMMARY
SEER 1000
Ogetemed 1015-TD-0073-00
2013-03-19
9. Discussion of Non-Clinical Tests Performed for Determination of Substantial Equivalence are as follows:
Non-clinical testing that has been conducted includes:
- a. Electromagnetic compatibility evaluation according to IEC 60601-1-2;
- b. Electrical safety test according test to IEC 60601-1
- c. ECG performance test according to AAMI ANSI EC 38
None of the testing demonstrated that the SEER 1000 brought up any issues of safety or effectiveness.
10. Discussion of Clinical Tests Performed:
No clinical testing was performed in order to support safety or effectiveness.
11. Conclusion:
The Holter recorder SEER 1000 is identical in indications for use to its predicate device and very similar in functionality, design, material and performance to applicable standards. The main modification is the implementation of the Bluetooth wireless technology as used in the CM 3000-12BT instead infrared as used in the SEER Light. Generally, there was a process of miniaturization for the complete device, so that it is now smaller and lighter.
The test results in this submission demonstrated that these small differences do not raise any new questions of safety and effectiveness to the subject device and the subject device is substantially equivalent to the predicate devices.
3
Image /page/3/Picture/0 description: The image shows the logo for the Department of Health & Human Services - USA. The logo features a stylized eagle with three lines representing its body and wings. The eagle is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
July 26, 2013
GETEMED Medizin-und Informationstechnik AG c/o Dr. Bert Schadow Regulatory Affairs Manager Oderstr. 77 Teltow 14513 GERMANY
Re: K130785
Trade/Device Names: SEER 1000 Regulatory Number: 21 CFR 870.2800 Regulation Name: Medical Magnetic Tape Recorder Regulatory Class: Class II (Two) Product Code: MWJ Dated: June 25, 2013 Received: June 28, 2013
r
Dear Dr. Schadow:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Dr. Bert Schadow
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDeyices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
M. A. Stillerman
for Bram D. Zuckerman Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known): Device Name: SEER 1000
Indication for Use:
The SEER 1000 is a Holter recorder which is indicated for patients who may benefit from a long-term continuous electrocardiographic (ECG) recording, including, but not limited to, those with complaints of palpitations, syncope, chest pain, shortness of breath, or those that need to be monitored to judge their current cardiac functionality.
Prescription Use X __
AND/OR
Over-The Counter Use _
(Part 21 CFR 801 Subpart D)
(21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation
. A. S. Hillman
Page 1 of ____________________________________________________________________________________________________________________________________________________________________